Gabelli Funds LLC Boosts Stock Position in Olink Holding AB (publ) (NASDAQ:OLK)

Gabelli Funds LLC lifted its position in Olink Holding AB (publ) (NASDAQ:OLK) by 5.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 560,061 shares of the company’s stock after purchasing an additional 28,826 shares during the quarter. Gabelli Funds LLC owned about 0.45% of Olink Holding AB (publ) worth $14,270,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Assetmark Inc. lifted its position in Olink Holding AB (publ) by 30.5% during the fourth quarter. Assetmark Inc. now owns 2,874 shares of the company’s stock valued at $72,000 after purchasing an additional 672 shares during the period. Blackstone Inc. lifted its holdings in shares of Olink Holding AB (publ) by 42.0% in the 1st quarter. Blackstone Inc. now owns 11,408 shares of the company’s stock valued at $268,000 after buying an additional 3,373 shares during the period. PenderFund Capital Management Ltd. purchased a new stake in shares of Olink Holding AB (publ) in the fourth quarter worth about $393,000. Ardent Capital Management Inc. acquired a new stake in Olink Holding AB (publ) during the first quarter worth about $470,000. Finally, Alpine Global Management LLC acquired a new stake in Olink Holding AB (publ) during the first quarter worth about $486,000. Institutional investors and hedge funds own 30.19% of the company’s stock.

Olink Holding AB (publ) Stock Performance

Shares of NASDAQ:OLK opened at $26.08 on Tuesday. Olink Holding AB has a 12-month low of $14.10 and a 12-month high of $26.09. The business has a 50 day moving average of $26.08 and a two-hundred day moving average of $24.77. The company has a market capitalization of $3.24 billion, a PE ratio of -96.59 and a beta of 0.52.

About Olink Holding AB (publ)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.